We are live on ! Find out more
SPHS

Sophiris Bio, Inc.
SPHS

Delisted

SPHS was delisted on the 11th of March, 2020.

Back to rankings

27 hedge funds and large institutions have $1.24M invested in Sophiris Bio, Inc. in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

8% more funds holding

Funds holding: 25 → 27 (+2)

65% less capital invested

Capital invested by funds: $3.56M → $1.24M (-$2.32M)

Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
2
Closed
5
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$238K
2
Renaissance Technologies
Renaissance Technologies
New York
+$103K
3
WS
Wedbush Securities
California
+$40.9K
4
SM
Sabby Management
Florida
+$19.2K
5
PAG
Private Advisor Group
New Jersey
+$9.08K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$2.21M
2
BO
BRR OpCo
Ohio
-$23K
3
Victory Capital Management
Victory Capital Management
Texas
-$3K
4
VF
Virtu Financial
New York
-$1.03K
5
Barclays
Barclays
United Kingdom
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$461K – – –
Wells Fargo
2
Wells Fargo
California
$194K +$238K +523,933 New
HP
3
Hikari Power
Japan
$111K – – –
PAI
4
Palo Alto Investors
California
$91K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$90K – – –
Renaissance Technologies
6
Renaissance Technologies
New York
$84K +$103K +226,019 New
SM
7
Sabby Management
Florida
$68K +$19.2K +42,378 New
WS
8
Wedbush Securities
California
$33K +$40.9K +90,000 New
Northern Trust
9
Northern Trust
Illinois
$26K – – –
VF
10
Virtu Financial
New York
$21K -$1.03K -2,274 -4%
PAG
11
Private Advisor Group
New Jersey
$15K +$9.08K +20,000 +100%
ACM
12
Alpha Capital Management
Texas
$13K – – –
Deutsche Bank
13
Deutsche Bank
Germany
$6K +$7.96K +17,524 New
LPL Financial
14
LPL Financial
California
$4K – – –
UBS Group
15
UBS Group
Switzerland
$4K +$2.69K +5,914 +107%
KCM
16
Kathmere Capital Management
Pennsylvania
$4K +$4.61K +10,150 New
Morgan Stanley
17
Morgan Stanley
New York
$2K -$222 -488 -10%
AG
18
Advisor Group
Arizona
$2K – – –
ACM
19
AUA Capital Management
Pennsylvania
$2K – – –
Group One Trading
20
Group One Trading
Illinois
$2K +$1.18K +2,600 +130%
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$1K +$454 +1,000 +93%
PNC Financial Services Group
22
PNC Financial Services Group
Pennsylvania
$1K +$1.14K +2,500 New
FDCDDQ
23
Federation des caisses Desjardins du Quebec
Quebec, Canada
$67 – – –
AC
24
Armistice Capital
New York
– -$2.21M -1,793,666 Closed
BO
25
BRR OpCo
Ohio
– -$23K -40,000 Closed
1
2

SPHS Hedge Fund Activity: Q4 2019 in Review

27 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q4 2019, worth a combined $1.24M — down 65% from $3.56M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new SPHS positions and 5 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Wells Fargo, opening a new position worth an estimated $238K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.21M sold.

  • 27 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q4 2019, up from 25 in Q3 2019.
  • Funds reported $1.24M of Sophiris Bio, Inc. stock for Q4 2019, down 65% quarter-over-quarter.
  • 7 funds opened new Sophiris Bio, Inc. positions in Q4 2019 and 5 closed out, a net change of +2 holders.
  • The largest Sophiris Bio, Inc. buyer in Q4 2019 was Wells Fargo, an estimated $238K added.
  • The largest Sophiris Bio, Inc. seller in Q4 2019 was Armistice Capital, an estimated $2.21M sold.

Based on aggregated 13F filings for Q4 2019.